title: The plasma membrane lipid composition affects fusion between cells and model membranes.
abstract: Investigations were carried out on the effect of plasma membrane lipid modifications on the fusogenic capacity of control and ras-transformed fibroblasts. The plasma membrane lipid composition was modified by treatment of cells with exogenous phospholipases C and D, sphingomyelinase and cyclodextrin. The used enzymes hydrolyzed definite membrane lipids thus inducing specific modifications of the lipid composition while cyclodextrin treatment reduced significantly the level of cholesterol. The cells with modified membranes were used for assessment of their fusogenic capacity with model membranes with a constant lipid composition. Treatment with phospholipases C and D stimulated the fusogenic potential of both cell lines whereas the specific reduction of either sphingomyelin or cholesterol induced the opposite effect. The results showed that all modifications of the plasma membrane lipid composition affected the fusogenic capacity irrespective of the initial differences in the membrane lipid composition of the two cell lines. These results support the notion that the lipid composition plays a significant role in the processes of membrane-membrane fusion. This role could be either direct or through modulation of the activity of specific proteins which regulate membrane fusion.
authors.affiliation: Department of Cytology, Histology and Embryology, Biological Faculty, Sofia University, Sofia, Bulgaria. rpankov@biofac.uni-sofia.bg
authors.forename: Roumen
authors.initials: R
authors.lastname: Pankov
authors.forename: Tania
authors.initials: T
authors.lastname: Markovska
authors.forename: Peter
authors.initials: P
authors.lastname: Antonov
authors.forename: Lidia
authors.initials: L
authors.lastname: Ivanova
authors.forename: Albena
authors.initials: A
authors.lastname: Momchilova
mesh_terms: D000818:Animals; D002462:Cell Membrane / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism*; D003505:Cyclodextrins / Q000494:pharmacology; D006801:Humans; D050356:Lipid Metabolism; D008055:Lipids / Q000032:analysis* / Q000737:chemistry*; D008561:Membrane Fusion; D008567:Membranes, Artificial; D051379:Mice; D010739:Phospholipase D / Q000378:metabolism; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism; D010738:Type C Phospholipases / Q000378:metabolism; D018631:ras Proteins / Q000235:genetics / Q000378:metabolism
chemical_list: D003505:Cyclodextrins; D008055:Lipids; D008567:Membranes, Artificial; D010738:Type C Phospholipases; D013108:Sphingomyelin Phosphodiesterase; D010739:Phospholipase D; D018631:ras Proteins